Evercross
Payments companies reported to CMS as associated with Evercross. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Evercross, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Evercross
These are the largest totals companies reported as associated with Evercross. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brian Derubertis | New York, NY | Vascular Surgery | $2,250.00 |
| Jeffrey Carr | Tyler, TX | Interventional Cardiology | $1,312.50 |
| Nicole Ilonzo | Brooklyn, NY | Vascular Surgery | $812.50 |
| Sahil Parikh | New York, NY | Interventional Cardiology | $750.00 |
| Iftekhar Baig | Bradenton, FL | Cardiovascular Disease | $562.50 |
| Ryan Lydon | Rochester, NY | Vascular Surgery | $193.37 |
| Ignatius Lau | New York, NY | Vascular Surgery | $120.91 |
| Scott Sundick | Westfield, NJ | Vascular Surgery | $120.17 |
| Yelena Bishop | San Jose, CA | Physician Assistant | $60.46 |
| Bhaskar Purushottam | Rapid City, SD | Cardiovascular Disease | $43.60 |
Prescribed Evercross?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.